These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30843199)

  • 1. Acral hemorrhagic blisters induced by reviparin.
    Pathania YS; Md AB
    Int J Dermatol; 2019 Nov; 58(11):1329-1330. PubMed ID: 30843199
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare cutaneous manifestation of hemorrhagic bullae to low-molecular-weight heparin and fondaparinux: report of two cases.
    Komforti MK; Bressler ES; Selim MA; Bressler GS; Ortel TL
    J Cutan Pathol; 2017 Jan; 44(1):104-106. PubMed ID: 27766660
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficient ambulatory and post-discharge thromboprophylaxis with fully automated pens].
    Höntzsch D; Scheffer J; Hafner S
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1060-2. PubMed ID: 9574332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.
    Rao SV; Melloni C; Myles-Dimauro S; Broderick S; Kosinski AS; Kleiman NS; Dzavík V; Tanguay JF; Chandna H; Gammon R; Rivera E; Alexander JH; Fier I; Roach J; Becker RC;
    Circulation; 2010 Apr; 121(15):1713-21. PubMed ID: 20368520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity challenged by subcutaneous Bemiparin.
    Moreno Escobosa MC; Moya Quesada MC; Granados SC; Amat López J
    Allergol Immunopathol (Madr); 2011; 39(5):309-10. PubMed ID: 21129837
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced hemorrhagic blisters.
    Roux J; Duong TA; Ingen-Housz-Oro S; Valeyrie-Allanore L; Ortonne N; Chosidow O; Wolkenstein P
    Eur J Dermatol; 2013; 23(1):105-7. PubMed ID: 23238270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukocytoclastic vasculitis after injection of low-molecular-weight heparin (letter)].
    de Bats B; Rivard L; Bellemin B; Duflo F; Allaouchiche B; Chassard D
    Presse Med; 2000 Oct; 29(29):1604. PubMed ID: 11072362
    [No Abstract]   [Full Text] [Related]  

  • 10. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial.
    Kujath P; Eckmann C; Misselwitz F
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):337-45. PubMed ID: 12516683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
    Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D;
    Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
    Wellington K; McClellan K; Jarvis B
    Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 15. Proliferative Sweet syndrome associated with pregnancy and low-molecular-weight heparin sodium.
    Zhang W; Wei S; Peng X; Xie S; Zeng K; Lai K
    Scand J Rheumatol; 2019 Sep; 48(5):428-429. PubMed ID: 30907689
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-Induced Bullous Hemorrhagic Dermatosis: A Report of an Exceptionally Exuberant Case and Literature Review.
    Cortez de Almeida RF; Vita Campos C; Daxbacher EL; Jeunon T
    Am J Dermatopathol; 2021 Jul; 43(7):497-505. PubMed ID: 33795557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.
    Planès A; Vochelle N; Fagola M; Bellaud M
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):499-505. PubMed ID: 9819000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsuspected Colonic Hemorrhage Found on Screening Colonoscopy.
    Jangouk P; Chang JJ; Imaeda AB
    Gastroenterology; 2017 May; 152(6):e10-e11. PubMed ID: 28384453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
    Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia E; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R; Karsch KR
    Z Kardiol; 1997 Aug; 86(8):581-91. PubMed ID: 9417748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.